Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders ArriveV Craig Jordan
Breast Cancer Research and Treatment|August 16, 2021
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen teamV Craig Jordan
Cancer Prevention Research (Philadelphia, Pa.)|July 17, 2020
Molecular Mechanism for Breast Cancer Incidence in the Women's Health InitiativeV Craig Jordan
The Lancet. Oncology|February 8, 2018
The Study of Letrozole Extension (SOLE) revisitedV Craig Jordan
Oncology (Williston Park, N.Y.)|September 22, 2006
A STAR is bornV Craig Jordan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The science of selective estrogen receptor modulators: concept to clinical practiceV Craig Jordan
Nature Reviews. Cancer|December 23, 2006
Chemoprevention of breast cancer with selective oestrogen-receptor modulatorsV Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
The ups and downs of the estrogen receptorV Craig Jordan
Nature Reviews. Drug Discovery|March 4, 2003
Tamoxifen: a most unlikely pioneering medicineV Craig Jordan
Journal of the National Cancer Institute|October 2, 2014
Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapyV Craig Jordan
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders ArriveV Craig Jordan
Breast Cancer Research and Treatment|August 16, 2021
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen teamV Craig Jordan
Cancer Prevention Research (Philadelphia, Pa.)|July 17, 2020
Molecular Mechanism for Breast Cancer Incidence in the Women's Health InitiativeV Craig Jordan
The Lancet. Oncology|February 8, 2018
The Study of Letrozole Extension (SOLE) revisitedV Craig Jordan
Oncology (Williston Park, N.Y.)|September 22, 2006
A STAR is bornV Craig Jordan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The science of selective estrogen receptor modulators: concept to clinical practiceV Craig Jordan
Nature Reviews. Cancer|December 23, 2006
Chemoprevention of breast cancer with selective oestrogen-receptor modulatorsV Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
The ups and downs of the estrogen receptorV Craig Jordan
Nature Reviews. Drug Discovery|March 4, 2003
Tamoxifen: a most unlikely pioneering medicineV Craig Jordan
Journal of the National Cancer Institute|October 2, 2014
Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapyV Craig Jordan
Pageof 22